seven patients with advanced multiple myeloma , refractory to therapy with alkylating agent-vad ( vincristine-adriamycin-dexamethasone ) , received a regimen combining high-dose melphalan with total body irradiation supported by autologous bone marrow transplantation .
C0077973
vad
C0011777
dexamethasone